LAS VEGAS, Feb. 21, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, launched today at HIMSS the ...
For over 100 years, The Union World Conference on Lung Health has come together to present the latest scientific research in all aspects of lung health. This year's event falls shortly after the ...
As the diagnostic test menu has increased in size and complexity, healthcare providers are in great need of advice on appropriate test selection and result interpretation. To address this need, ...
This session introduces the keypoints in validating RT-PCR testing of SARS-CoV-2, and presents findings at a provincial center of CoVID-19 on positive rate of molecular testing from multiple specimen ...
First Decade of the National Cancer Institute's Affordable Cancer Technologies Program: Accelerating Translational Technology Research and Development for Cancer Globally The growing cancer burden and ...
Experts at Bengaluru conclave emphasised scalable, affordable diagnostic innovation, regulatory frameworks and global market ...
EGFR G719X 2 (1.3) No additional alterations detected (including one QC for RNAl) 2 EGFR L861Q 4 (2.7) No additional alterations detected 4 DNA and RNA were extracted from formalin-fixed ...
The dominoes are falling on European clinical trials as the unintended consequences of the EU’s In Vitro Diagnostics Regulation take hold. Last year’s implementation of the regulation has resulted in ...
SALT LAKE CITY, Nov. 20, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX ) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results